Market Overview

UPDATE: JP Morgan Downgrades Affymetrix to Underweight

Related AFFX
Affymetrix (AFFX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Mid-Afternoon Market Update: Yelp Shares Show Strength as Pandora Continues to Fall on Poor Guidance
Related AFFX
Mid-Day Market Update: Green Mountain Coffee Shares Jump After Coca-Cola Deal; Twitter Falls
Mid-Morning Market Update: Markets Rise; General Motors Earnings Miss Estimates

JP Morgan lowered its rating on Affymetrix (NASDAQ: AFFX) from Neutral to Underweight on macro risk.

JP Morgan said, "We are lowering our rating on AFFX from Neutral to Underweight on the poor outlook for arrays in academic/research, and limited flexibility for capital deployment following the eBiosciences acquisition. ... With increasing competition in arrays from Illumina and Agilent (Roche even felt the need to exit arrays recently), as well as sequencing and other platforms (desktop sequencers, nanofluidics platforms, etc.), we see little to stabilize the array business, particularly against the backdrop of a challenging U.S. and EU funding environment."

Affymetrix closed at $4.41 on Tuesday.

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Most Popular

Related Articles (AFFX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free